Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039364
Filing Date
2023-08-08
Accepted
2023-08-08 07:30:55
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20230630.htm   iXBRL 10-Q 3235231
2 EX-31.1 beam-ex31_1.htm EX-31.1 22529
3 EX-31.2 beam-ex31_2.htm EX-31.2 22585
4 EX-32.1 beam-ex32_1.htm EX-32.1 13112
5 EX-32.2 beam-ex32_2.htm EX-32.2 13141
  Complete submission text file 0000950170-23-039364.txt   11892459

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT beam-20230630_def.xml EX-101.DEF 263256
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20230630_pre.xml EX-101.PRE 411048
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20230630_lab.xml EX-101.LAB 473765
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT beam-20230630_cal.xml EX-101.CAL 47932
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20230630.xsd EX-101.SCH 63155
72 EXTRACTED XBRL INSTANCE DOCUMENT beam-20230630_htm.xml XML 2695792
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 231149341
SIC: 2836 Biological Products, (No Diagnostic Substances)